The therapeutic potential of Ni was tested in in vitro models of sarcopenia (dexamethasone-induced myotube atrophy), cancer cachexia (tumor necrosis factor-α treated myotubes) and myogenesis, in addition to an animal model of dexamethasone-induced skeletal muscle atrophy. Here, TNF is linked to cancer.